Stockscreener 앱 받기
1.03%
시간 외 거래:
전일 마감가:
$1.94
열려 있는:
$1.92
하루 거래량:
358.01K
Relative Volume:
1.13
시가총액:
$110.58M
수익:
$16.45M
순이익/손실:
$-73.60M
주가수익비율:
-1.5318
EPS:
-1.2795
순현금흐름:
$-46.25M
1주 성능:
+15.98%
1개월 성능:
+8.29%
6개월 성능:
-10.91%
1년 성능:
-6.67%
1일 변동 폭
$1.91
$1.97
1주일 범위
$1.665
$1.97
52주 변동 폭
$1.65
$2.41
시어 Stock (SEER) Company Profile
명칭
Seer Inc
전화
650-453-0000
주소
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Compare SEER vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SEER
Seer Inc
|
1.96 | 109.46M | 16.45M | -73.60M | -46.25M | -1.2795 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
시어 Stock (SEER) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-07-05 | 재개 | JP Morgan | Neutral |
| 2023-01-04 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-08-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2020-12-29 | 개시 | BofA Securities | Neutral |
| 2020-12-29 | 개시 | Cowen | Outperform |
| 2020-12-29 | 개시 | JP Morgan | Overweight |
| 2020-12-29 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
시어 주식(SEER)의 최신 뉴스
Activist investors bid to buy a Redwood City company and take it private - The Business Journals
Seer shares jump on takeover proposal - MSN
Seer jumps 10% on $2.25 per share all-cash acquisition bid from activist group - MSN
Seer Confirms Receipt of Proposal and Director Nominations from Radoff-JEC Group - marketscreener.com
Seer, Inc. Receives Unsolicited Buyout Proposal and Board Nominee Slate from Radoff-JEC Group; No Immediate Stockholder Action Required 1 - Minichart
Seer (SEER) Receives Acquisition Proposal and Board Nominations - GuruFocus
Seer Receives Unsolicited Takeover Proposal, Eyes Proxy Battle - TipRanks
Seer receives $2.25/share unsolicited proposal plus contingent value right, nominates three directors - TradingView — Track All Markets
Unsolicited $2.25-per-share offer and proxy challenge hit Seer (SEER) - Stock Titan
[DFAN14A] Seer, Inc. SEC Filing - Stock Titan
Activist group offers $2.25 cash and CVR for Seer (SEER) in 13D update - Stock Titan
Seer Receives Unsolicited Acquisition Proposal, Director Nominations - National Today
Seer jumps 10% on $2.25 per share all-cash acquisition bid from activist group (update) - MSN
Seer receives $2.25 per share buyout proposal from investor group By Investing.com - Investing.com Australia
Bradley L. Radoff and Michael Torok submitted a non-binding proposal to acquire remaining 93.81% stake in Seer, Inc. for approximately $130 million. - marketscreener.com
Seer, Inc. Confirms Receipt of Acquisition Proposal from Radoff-JEC Group - Quiver Quantitative
Seer faces $2.25-a-share buyout bid and 3 board nominees - Stock Titan
Seer (SEER) Faces Acquisition Proposal and Board Nominations - GuruFocus
Radoff-JEC Group Proposes Seer, Inc. Acquisition - National Today
The Radoff-JEC Group Submits Non-Binding Proposal to Acquire Seer, Inc. - Investing News Network
Seer Shares Jump On Takeover ProposalSeer (NASDAQ:SEER) - Benzinga
Incorrect alert on Seer Inc's FY revenue outlook withdrawn - marketscreener.com
Seer receives $2.25 per share takeover bid from activist investors By Investing.com - Investing.com South Africa
SEER PE Ratio & Valuation, Is SEER Overvalued - Intellectia AI
Seer Joins Thermo Fisher Tools In Large-Scale Proteomics Effort - Sahm
US Market Recap: What is the target price for Seer Inc stockTrade Analysis Report & Daily Market Momentum Tracking - baoquankhu1.vn
Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples - Investing News Network
Seer, Inc. and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 Precise Sg100k Samples - marketscreener.com
Seer Inc stock: Why this proteomics innovator merits your attention now - AD HOC NEWS
Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries - 富途牛牛
Whale Trades: Can Seer Inc deliver consistent EPS growth2026 Patterns & Weekly Consistent Profit Watchlists - baoquankhu1.vn
BRKR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Fundamentals Check: Is now the right time to enter Seer Inc2026 Catalysts & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Bruker, Seer Each Claim Partial Win in US Patent Board Ruling - 富途牛牛
Seer, Inc. (NASDAQ:SEER) Sees Large Decline in Short Interest - MarketBeat
Seer retains patent claims in USPTO review of protein analysis tech By Investing.com - Investing.com South Africa
Seer retains patent claims in USPTO review of protein analysis tech - Investing.com Australia
Seer Strengthens Proteograph IP Following Favorable Patent Ruling - TipRanks
PTAB upholds key Seer (Nasdaq: SEER) Proteograph patent claims - Stock Titan
Nasdaq Moves: Whats next for Seer Inc stockAnalyst Downgrade & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Bullish Seer Insiders Loaded Up On US$5.29m Of Stock - Yahoo Finance
Risk Recap: Will Seer Inc outperform the market in YEAR2026 Sector Moves & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Analyst Downgrade: Does Seer Inc meet Warren Buffetts criteriaTake Profit & Real-Time Buy Signal Notifications - baoquankhu1.vn
US Market Wrap: Should you avoid Seer Inc stock right now2026 Big Picture & Real-Time Volume Analysis Alerts - baoquankhu1.vn
TD Cowen Maintains Seer Inc(SEER.US) With Buy Rating - 富途牛牛
Seer (NASDAQ:SEER) Shares Down 2.6%Here's What Happened - MarketBeat
SEER Should I Buy - Intellectia AI
SEER.O Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
SEER.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
SEER News & Events - Intellectia AI
시어 (SEER) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.69%
0.25%
자본화:
|
볼륨(24시간):